For the Inventor, By the Inventor

Enter assignee name

Salt Lake City, UT, United States of America

Iomed, Inc.

USPTO Granted Patents = 32

% Expired Patents = 9.4

CIPO Patents = 1

EPO Patents = 1

Forward Citations = 1,042

Loading Chart...

Loading Chart...

27 inventors (with patents filed for the assignee):

Jon E Beck (20 out of 30 patents)

Tomasz J Petelenz (11 out of 32 patents)

Lindsay B Lloyd (9 out of 9 patents)

4. Stephen C Jacobsen (6 out of 263 patents)

5. Robert L Stephen (4 out of 35 patents)

6. Gregory A Fischer (3 out of 5 patents)

7. Alex Koss (2 out of 2 patents)

8. Thomas M Parkinson (2 out of 2 patents)

9. Malgorzata Szlek (2 out of 2 patents)

10. Philippe Millot (2 out of 8 patents)

11. William F Felman (2 out of 2 patents)

12. Clay H Holt (2 out of 2 patents)

13. Robert F Hause, Jr (1 out of 13 patents)

14. Malcolm E Taylor (1 out of 23 patents)

15. Edward M Kolvek (1 out of 19 patents)

Core Competencies:

Iontophoretic Device

Ocular Iontophoresis

Bioelectrode

Drug Delivery

Current Distribution

Transcutaneous Administration

Hydration Assembly

Electrical Resistance

Electrode Connector

Fluid Retention Assembly

Rehydratable Product

Skin Treatment

32 patents: Sort by Forward Citations

1. 7252655 - Ocular iontophoretic apparatus handle (2007-08-07),

2. 7137965 - Device for the iontophoretic delivery of a drug (2006-11-21),

3. 6953446 - Method and device for the iontophoretic delivery of a drug (2005-10-11),

4. 6823202 - Iontophoretic power supply (2004-11-23),

5. 6731987 - Electrode for the transferring an electric current through a patient's skin (2004-05-04),

6. 6731977 - Iontophoretic electrode with improved current distribution (2004-05-04),

7. 6728573 - Ocular iontophoretic apparatus handle (2004-04-27),

8. 6697668 - Ocular iontophoretic device and method for using the same (2004-02-24),

9. 6687536 - Connection system for an iontophoretic drug delivery device (2004-02-03),

10. 6579276 - Ocular iontophoretic device and method for inhibiting vascular endothelial growth factor (VEGF) using the same (2003-06-17),

11. 6546284 - Fluid retention assembly for an iontophoretic delivery device and associated method for preparing the same (2003-04-08),

12. 6546283 - High current density iontophoretic device and method of use thereof (2003-04-08),

13. 6539251 - Ocular iontophoretic apparatus (2003-03-25),

14. 6488428 - Fluid assembly containing a breaking component for release of fluid and method therefore (2002-12-03),

15. 6477411 - Bioelectrode having a crushable hydrating assembly and associated method (2002-11-05),

Company Overview

Iomed, Inc. is a biotechnology company based in Salt Lake City, Utah, specializing in innovative drug delivery systems. The company focuses on developing advanced technologies that enhance the efficacy and safety of therapeutic treatments. Iomed's proprietary platforms are designed to improve patient outcomes through targeted delivery mechanisms, particularly in the fields of oncology and chronic disease management. With a commitment to research and development, Iomed aims to transform the landscape of medical therapies and improve the quality of life for patients.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

32 Patents

#45 in Salt Lake City, UT

#119 in Utah

#10,607 in US

#20,697 in the World

Salt Lake City, UT, United States of America

Iomed, Inc.

Forward Citations = 1,042

27 inventors:

Jon E Beck (20 out of 30 patents)

Tomasz J Petelenz (11 out of 32 patents)

Lindsay B Lloyd (9 out of 9 patents)

4. Stephen C Jacobsen (6 out of 263 patents)

5. Robert L Stephen (4 out of 35 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Iomed, Inc.. Retrieved from https://idiyas.com/company/iomed

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…